
|Articles|November 1, 1997
The American Journal of Managed Care
- November 1997
- Volume 3
- Issue 11
Cardiovascular Drug Prescribing Patterns: Where is the Evidence of Improvement?
Author(s)Sarah A. Spinler, PharmD
Advertisement
Articles in this issue
about 28 years ago
Healthcare Utilization Among Women with Eating Disordered Behaviorabout 28 years ago
Postpartum Depressionabout 28 years ago
Pharmaceutical Considerations of Common Herbal Medicineabout 28 years ago
When Is a Cost-Effectiveness Claim Valid? How Much Should the FDA Care?about 28 years ago
Treatment Patterns for Heart Failure in a Primary Care Environmentabout 28 years ago
Enhancement of Compliance Among Patients with HypertensionNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA to Accept Deidentified Real-World Evidence for Select Medical Device Applications
2
ACA Subsidy Expiration Raises Concerns for Behavioral Health Access and ED Strain
3
HIV in 2025 Defined by Challenges Throughout the Year, Despite Some Advances
4
FDA Approves Intranasal Etripamil for Type of Arrhythmia
5









































